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Abstract
Background: Dilated cardiomyopathy (DCM) and chronic mitral valve disease (CMVD) in dogs are associated with
heart chamber enlargement, also of the left atrium. DCM is often accompanied by rhythm disturbances (mainly atrial
fibrillation or ventricular arrhythmias). In CMVD, arrhythmias are observed less frequently. It is still unclear whether
left atrial enlargement in these diseases results from volume overload or if it is also connected with other factors
(e.g. rhythm disturbances).
This study was conducted on the left atrial myocardial specimens from 31 dogs, including those from 16 dogs
with clinically diagnosed DCM and 15 dogs with CMVD. After fixation and staining (using haematoxylin-eosin and
Masson-Goldner trichrome stain), the specimens underwent evaluation. Parenchymal changes (fibrosis, fatty
infiltration, and vessel narrowing), degenerative changes (loss of striation, changes in cardiomyocyte structure,
and abnormal cell nuclei) and the presence of inflammatory infiltrates were assessed.
Results: More interstitial fibrosis (median 4 vs. 2.5 grid fields; p < 0.05) and less perivascular fibrosis (median score
1 vs. 2; p < 0.05) was observed in the DCM group compared to the CMVD group. Moreover, less distinct vessel
narrowing was observed in the DCM group than in the CMVD group (median lumen area ratio 0.3 vs. 0.26
respectively; p < 0.05). Dogs with DCM showed more strongly defined degenerative changes than the CMVD
dogs (median nuclei enlargement score 3 vs. 1, median loss of striation score 3 vs. 2 and median structural
alterations score 3 vs. 2, respectively; p < 0.05).
Conclusion: The obtained results indicate a different nature of changes occurring in the left atrial myocardium of
dogs with DCM compared to dogs with mitral valve disease, including differences in vessel narrowing, cardiomyocyte
degeneration and in the distribution of connective tissue.
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Background
Dilated cardiomyopathy (DCM) is a polyetiological dis-
ease characterised by a dilation of heart chambers
(mainly the left ventricle and left atrium) without other
significant structural heart defects. In some cases, it is
combined with myocardial failure [1, 2]. It is mostly
encountered in large and giant breed dogs but it can also
develop in dogs of other breeds (e.g. English and American
cocker spaniels, poodles and Portuguese water dogs) [1–7].
During the development of DCM the radiographic,
echocardiographic and post-mortem examinations reveal
an enlargement of the left ventricle and left atrium or an
enlargement of all the heart chambers [1, 2, 4, 5, 7]. The
ventricular dilation in DCM alters the geometry of atrio-
ventricular valves, which results in valvular insufficiency.
Mitral regurgitation increases left atrial pressure that may
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worsen the pathological remodelling of the left atrium and
the left ventricle and independently stimulate the dilation
of the heart chambers [8]. The disease is often accom-
panied by rhythm disturbances, mainly atrial fibrillation.
However, there is no consent whether atrial fibrillation is
the cause or result of atrial enlargement [9].
The histopathologic examination of the samples obtained
from dogs with DCM demonstrates changes in the myocar-
dial structure. There are two well-described forms of histo-
pathologic lesions in the ventricular specimens of dogs with
DCM: the attenuated wavy fibre type (AWF) and the
fatty infiltration-degenerative (FID) type. Those lesions
are mostly encountered in specimens from the left ven-
tricle, but can also occur in the myocardium of the right
ventricle and interventricular septum [1, 2, 4, 5, 8, 10].
Our previous study showed similar changes in atrial speci-
mens from dogs with FID types of lesions in the ventricles.
In dogs with the AWF type of ventricular lesions, the
changes observed in atria can resemble either AWF or
FID types of changes [11]. The attenuation of cardiomyo-
cytes is a specific pathological feature of DCM. However,
vacuolisation, extensive fibrosis and fatty infiltration may
also occur in the ventricular walls during the course of
that disease [1, 2, 4, 7]. Due to the fact that there is a simi-
larity between the FID type of DCM and arrhythmogenic
right ventricular cardiomyopathy, it is important to accur-
ately characterise the disease based on the clinical and
histopathological examinations [5].
The mechanism of changes occurring in the atrial
myocardial structure in DCM is not well defined. It is
suspected that the structural protein defects, impaired
tissue oxygen supply and other factors may play a role in
the development of the disease [1, 2]. It is not well
understood whether the macroscopic and microscopic
changes within the atria in dogs with DCM are a result
of primary remodelling, the presence of arrhythmias, or
a response of the cardiac tissue to functional disturbances,
including volume overload (which also occurs in mitral
valve disease).
Canine chronic mitral valve disease (CMVD) is the most
common cardiovascular disease in dogs and the most
frequent cause of congestive heart failure in those animals.
The disease predominantly occurs in small breed dogs
(e.g. Cavalier King Charles spaniels, Yorkshire terriers,
dachshunds) and progresses with age [12–14]. The pro-
gressive dilation of the left ventricle and the left atrium
in CMVD results from degenerative changes and an in-
sufficiency of the mitral valve, leading to symptoms of
heart failure [15]. Histopathologic changes within the
ventricular walls include fibrosis and arteriosclerosis
without or with slight myocyte atrophy [16, 17].
The purpose of the study was a histopathologic com-
parison of the left atrial wall specimens obtained from
dogs with severe left atrial enlargement resulting from
clinically diagnosed dilated cardiomyopathy (DCM) or
chronic mitral valve disease (CMVD). To the authors’
knowledge, there are no detailed studies comparing histo-
pathologic changes occurring in the atria in those diseases.
Methods
Case selection
Thirty-one dogs aged from 4 to 19 years (23 males and 8
females) with either CMVD or DCM were included in
the study. Dogs met the inclusion criteria if they had an
enlarged left atrium according to an echocardiographic
examination (left atrial (LA)-to-aortic root (Ao) diameter
ratio; LA/Ao >1.7 [18]), which was confirmed in a post-
mortem examination. Dogs were included in the DCM
group if they had a dilated left ventricle and a decreased
fractional shortening (FS < 20 %) noted during an echo-
cardiographic examination [1, 2, 5] with normal or type
1 mitral valve lesions (according to Whitney [19]). Dogs
were included in the CMVD group if they had preserved
left ventricular systolic function (FS > 20 %, noted in the
echocardiographic examination) with type 3 or 4 mitral
valve lesions (according to Whitney [19]). At the time of
death or euthanasia, all dogs presented with stage D heart
failure (according to the ACVIM Consensus Statement [20]).
Ante-mortem examination
All animals underwent a clinical examination, echocardi-
ography and electrocardiography, and were treated and
re-examined every 6 months, until they died or were eu-
thanized due to heart failure refractory to treatment.
Only the LA/Ao ratio from the last examination of each
dog served as an inclusion criterion.
The ECG was performed in right lateral recumbency
using a 6-channel BTL SD08 device (BTL, UK) with I, II,
III, aVL, aVR, aVF, and precordial (V1-V6) lead record-
ings. The echocardiographic examination was performed
in standard views using the Aloka SSD 4000 and Aloka
Alpha7 machines and included the assessment of the
LA/Ao ratio, end-systolic and end-diastolic left ventricu-
lar measurements, ejection fractions and FS, blood vel-
ocity through the aortic and pulmonic valve, and the
function of the atrioventricular valves. The relative left
atrial size was estimated based on the LA/Ao. This par-
ameter was determined using standard images acquired
from a right short-axis view at the base of the heart. Es-
timates of left ventricular systolic function were obtained
from the index of circumferential myocardial contraction
and FS using the formula: FS[%] = ([LVIDd – LVIDs]/
LVIDd) ×100, where LVIDd and LVIDs are the internal
left ventricular dimensions at end-diastole and end-systole,
respectively. Left ventricular dilation was estimated based
on the comparison of chamber measurements (internal
diameter and wall thickness) to standard breed-specific
or body-weight specific values [21]. The function of the
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atrioventricular, pulmonary and aortic valves was exam-
ined using pulsed wave Doppler and color Doppler
techniques.
Post-mortem examination
The results of the echocardiographic examination (left
atrial and left ventricular enlargement) were confirmed
during the post-mortem examination, where the type of
mitral valve lesion was determined. Heart measurements
were taken using a manual 150 mm Beerendonk caliper,
measured to the nearest 1/20 mm. The measurements
were taken in planes compatible with those used during
the echocardiographic examination. Specimens from the
left atrial wall were collected from each dog for further
histopathologic analysis. They were fixed in 7 % buffered
formalin, embedded in paraffin blocks, sectioned at
6 μm, stained using the standard haematoxylin-eosin
(H&E) method and Masson-Goldner trichrome (for a
better visualisation of connective tissue), and underwent
a light microscopy evaluation. Photomicrographs of each
studied specimen were subjected to computer-assisted
image analysis, using a computer coupled to an optical
Olympus BX53 microscope, equipped with a Color View
IIIu digital Olympus camera (Olympus, Japan). A mor-
phometric analysis was performed using Cell^A software
(Olympus Soft Imaging Solution GmbH, Germany).
To accurately describe the histopathological changes
in the atria, specimens were evaluated for the presence
and severity of fibrosis, fatty infiltration, inflammatory
infiltration, intra-myocardial arterial narrowing and de-
generative changes in cardiomyocytes. The latter was
expressed as the presence of abnormal cell nuclei (swollen
nuclei with an altered structure surrounded by a “halo”),
loss of striation, and other features of degeneration (e.g.
swelling of the cardiomyocyte, blurring of the cell struc-
ture and alterations in staining).
The presence and severity of interstitial fibrosis and
fatty infiltration were evaluated after superimposing a
16-field grid over the digital image and counting the
number of fields that showed the presence of fatty infil-
tration or fibrosis (in 200× magnification, after Masson-
Goldner trichrome staining), as proposed by Lobo et al. [7].
The severity of perivascular fibrosis was assessed using
the following scoring system: 0, no fibrosis; 1, mild; 2,
moderate; 3, severe fibrosis (in 100× magnification, after
Mason-Goldner trichrome staining).
Inflammatory infiltrates were evaluated according to
the number of inflammatory cells in a field at a 400×
magnification (H&E staining).
Intra-myocardial arterial narrowing was assessed using
the lumen area ratio (LAR; the luminal area of the ves-
sel divided by the total vessel area, not including the
adventitia), as proposed by Falk et al. [16] (at 200×
magnification, after H&E staining).
Cardiomyocyte degenerative changes (abnormal cell nu-
clei, loss of striation and changes in cardiomyocyte struc-
ture) were assessed using the following scoring system: 0,
none or involving <25 % of the myofibres; 1, involving
25–50 % of the myofibres; 2, involving 50–75 % of the
myofibres; 3, involving >75 % of the myofibres (at 400×
magnification, after H&E staining).
Each of the features was evaluated in 20 randomly
chosen fields per slide (for fatty infiltrates, interstitial fi-
brosis, inflammatory infiltrates, and cardiomyocyte de-
generative changes) or in at least 10 vessels per slide (for
perivascular fibrosis and LAR), and a mean score was
subsequently calculated for the slide.
Ethical consideration
According to the Polish law [22], standard diagnostic pro-
cedures and studies conducted on animal tissue do not re-
quire permission from the Ethical Board. Oral consent for
the ante-mortem examination (electrocardiography and
echocardiography) was obtained from all owners, as those
examinations are used routinely to diagnose canine heart
disease.
Statistical analysis
A statistical analysis was performed using StatisticaPL®
software (StatSoft, Poland). The Shapiro-Wilk analysis
was used to test the data normality. The Mann–Whitney
U test (for data distributed non-normally) or Student’s t
test (for data distributed normally) were used to compare
groups. The level of statistical significance was set at
P < 0.05.
The results are shown as range and median values.
Results
The DCM group consisted of 16 dogs (9 Doberman
pinschers, 4 German shepherds, 2 boxers, and 1 great
Dane, aged 4–11 years, including 12 males and 4 females).
Seven specimens from the left ventricle presented with an
AWF type of lesion, while nine specimens had features of
a FID type of lesion. The CMVD group comprised 15 dogs
(10 mixed-breed dogs, 2 dachshunds, 1 Cairn terrier, 1
miniature pinscher, and 1 German pinscher, aged 8–19
years, including 11 males and 4 females) diagnosed with
mitral valve disease combined with an enlarged left
ventricle and left atrium (Table 1).
Dogs in the DCM group were significantly younger
and heavier than those from the CMVD group, but there
was no difference in the LA/Ao ratio between both
groups (Table 1). All dogs in the DCM group and 26.7 %
of dogs in the CMVD group had rhythm disturbances,
as shown in Table 1.
The results of the histopathological analysis are shown
in Table 2. The DCM group showed significantly more
interstitial fibrosis, less perivascular fibrosis, a higher
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LAR value, and no difference in fatty infiltration severity
compared to the CMVD group (Figs. 1 and 2). More-
over, we noted a significantly more cardiomyocyte de-
generative changes in the DCM group compared to the
CMVD group (Figs. 1 and 2). They included the presence
of abnormal cell nuclei, loss of striation and changes in
the structure of the cardiomyocytes. No difference in the
severity of inflammatory infiltrates was noted between
both groups. The inflammatory infiltration consisted of
single lymphocytes mainly localised subendocardially. The
average number of inflammatory cells per field did not
exceed 2 in any of the examined specimens.
Discussion
There have been numerous histopathological characteri-
sations of canine DCM [1, 2, 4, 7]. However, changes oc-
curring in the atrial tissue in the course of DCM remain
poorly described. Similarly to our findings, Everett et al.
[8] noted fibrosis and cardiomyocyte atrophy in speci-
mens from the atria in Doberman pinschers with DCM.
Those lesions were less extensive and less common than
the lesions found in specimens from ventricles in the
same animals.
According to Schaper et al. [23], normal cardiac tissue
in failing hearts in humans is replaced by fibrosis. This is
accompanied by changes within the cardiomyocyte nu-
clei (including nuclear enlargement). Sharov et al. [24]
noted a disruption in the structure of cardiomyocytes
with subsequent fibrosis in dogs with heart failure. The
authors associated myocardial fibrosis with changes in
the expression of structural proteins. We observed le-
sions in cardiomyocytes and interstitial tissue in both
groups, which may reflect the response of the heart to
volume overload, as described in the abovementioned
studies. In our study, there was more interstitial fibrosis
and nuclear enlargement in the DCM group.
When comparing ventricular specimens from dogs
showing DCM and CMVD, Falk et al. [17] noticed that
the majority of dogs with CMVD showed only a small
degree of cardiomyocyte atrophy in the ventricular speci-
mens or none at all. Such differences in the severity of car-
diomyocyte degeneration were also observed in our study.
Studies on dogs with CMVD showed that animals de-
veloping congestive heart failure present with lower values
of LAR as compared to controls, although this parameter
is highly variable in each dog [16]. Falk et al. [17] showed
that a decrease in LAR is directly associated with a de-
crease in fractional shortening in the left ventricle. This
suggests the presence of alterations in intra-myocardial
vessels in the course of heart dilation in CMVD. Although
LAR is not a highly reliable parameter [17], its greater
values observed in the DCM group in our study together
with lower values of perivascular fibrosis may indicate that
alterations in intra-mural vessels play a greater role in left
atrial enlargement in CMVD than in DCM.
DCM in dogs is often connected with the occurrence
of supraventricular and ventricular rhythm disturbances.
Sustained arrhythmias in CMVD occur less frequently
[1, 2, 5, 25, 26]. Noszczyk-Nowak et al. [27] and Crosara
et al. [26] demonstrated a higher risk of developing sup-
raventricular arrhythmias in dogs with an enlarged left
atrium, although this phenomenon is not well under-
stood. It has not been established whether arrhythmias,
also found in dogs in pre-clinical stages of DCM, are a
consequence of primary myocardial changes or if myo-
cardial lesions result from long-lasting rhythm distur-
bances and secondary heart chamber dilation [5, 28].
Recent studies [28–30] emphasize the role of myocar-
dial fibrosis in the development and progression of atrial
fibrillation (AF) of different aetiology in humans. Platanov
et al. [30] showed a significantly higher amount of
Table 1 Population study and clinical findings in the examined
groups
DCM group CMVD group p-value
n = 16 n = 15
age (median; range) [years] 9 (4–11) 15 (8–19) <0.001
weight (median; range) [kg] 31 (30–45) 11 (5–25) <0.001
arrhythmia (n) 16 4a
atrial fibrillation (n) 15 1
ventricular tachycardia (n) 1 -




LA/Ao (mean ± SD) 3.14 ± 0.31 2.44 ± 0.71 0.08
LA/Ao left-atrial-to-aorta ratio, SD standard deviation
aone dog showing both single atrial premature complexes and ventricular
premature complexes
Table 2 Histopathological findings in the examined groups
DCM group CMVD group p-value
n = 16 n = 15
interstitial fibrosis (median;
range)
4 (1–7) 2.5 (1–5) 0.036
perivascular fibrosis (median;
range)
1 (0–2) 2 (1–2) 0.006
fatty infiltration (median; range) 1 (0–10) 1 (0–6) 0.663





abnormal cell nuclei (median;
range)
3 (1–3) 1 (0–3) 0.008
loss of striation (median; range) 3 (1–3) 2 (0–3) 0.004
altered cardiomyocyte structure
(median; range)
3 (2–3) 2 (0–3) 0.004
inflammatory infiltration (median;
range)
0.36 (0–1.6) 0.35 (0–1.9) 0.796
LAR lumen area ratio
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connective tissue in heart specimens from patients with
AF, compared to patients without atrial rhythm distur-
bances. Nattel and Harada [31] highlighted the possible
role of fibrosis in cardiac conduction disturbances.
Frustaci et al. [32] noted changes in the atrial myocar-
dial structure (inflammation, non-inflammatory cardiomy-
opathy or fibrosis) in patients with lone atrial fibrillation
without coexisting heart chamber dilation (including atrial
diameter). Moreover, Tuomainen et al. [33] noted signifi-
cantly lower values of the left ventricular end-diastolic
diameter, left ventricular end-diastolic volume and left
ventricular end-systolic volume combined with a signifi-
cantly higher value of the left atrial diameter in patients
with chronic AF in DCM compared to patients with
DCM and a sinus rhythm. Considering that all dogs with
DCM in this study had an arrhythmia, it is impossible to
determine whether the observed changes are a consequence
of the primary myocardial disease or a consequence of
the arrhythmia.
One of the limitations of our study was a lack of dogs
with DCM without rhythm disturbances, which could
be compared to dogs included in the study. Dogs with
DCM often develop rhythm disturbances before the
development of clinical symptoms. Further studies
including dogs with DCM without arrhythmias may im-
prove our knowledge of the pathogenesis of this disease.
Another limitation was an observed difference between
body weight, age and breed distribution in both groups.
This was a result of the different clinical courses of both
diseases. DCM mostly occurs in young large-breed dogs,
while CMVD mostly occurs in old small-breed dogs. To
minimize those differences, we used an increased LA/Ao
ratio as an inclusion criterion. There was no difference in
the LA/Ao ratio between both groups. Therefore, we as-
sumed that the comparison of atrial remodelling in both
groups was justifiable.
The variety in the DCM group was a further limita-
tion of the study. We included dogs with idiopathic
DCM that developed arrhythmias in the course of the
disease and dogs presenting with AF in the first
examination. The latter dogs may have had tachycardia-
induced cardiomyopathy. However, all the dogs in the
DCM group did not respond well to treatment in late
stages of the disease. They developed severe heart
failure with left atrial enlargement, and presented
with severe tachyarrhythmia at the time of death or
prior to euthanasia. Hence, they were included in one
group.
Fig. 1 Histopathologic pattern of atrial myocardium in DCM group. a interstitial fibrosis (Masson-Goldner trichrome), b myocardial degeneration
presented by changes in cardiomyocyte structure, loss of striation and changes in cell staining (H&E)
Fig. 2 Histopathologic pattern of atrial myocardium in CMVD group. a fatty infiltration with slight amount of interstitial fibrosis (Masson-Goldner
trichrome), b perivascular fibrosis with slight amount of interstitial fibrosis (Masson-Goldner trichrome)
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The last limitation was a lack of assessment of atrial
pressure in the examined dogs prior to the histopatho-
logic examination in order to exclude its influence on
atrial remodelling. We attempted to minimise the possi-
bility of other reasons for atrial enlargement (e.g. mitral
stenosis) by performing an accurate ante-mortem and
post-mortem examination.
Conclusion
Dogs with dilated cardiomyopathy show a different distribu-
tion of connective tissue, have less severe intra-myocardial
arterial narrowing, and have more severe degenerative
changes in the cardiomyocytes of the left atrium compared
to dogs with chronic mitral valve disease. The changes noted
in the atrial tissue from dogs in both groups resemble
lesions noted in the ventricular tissue of dogs with the
same diseases. Those differences may indicate that the
atrial enlargement noted in DCM and CMVD has a dif-
ferent, disease-specific underlying mechanism and does
not result only from volume overload.
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